Treatment relative effect with 95% CI; and degree of certainty (adaptated from GRADE). method
Treament | Trials | |||||
---|---|---|---|---|---|---|
clinical deterioration | clinical improvement | deaths | PCR-negative conversion | |||
Immunostimulants drugs | - | - | - | OBS 715.00 [12.94; 39513.71], 1 study, I2=0% unassessable degree of certainty | ||
A EFFACER anticorps | 0 | - | - | - | - | |
acalabrutinib | 0 | - | - | - | - | |
anti-inflammatory therapies | 0 | - | - | - | - | |
Apilimod | 0 | - | - | - | - | |
corticosteroids | 0 | - | - | - | - | |
imatinib | 0 | - | - | - | - | |
Immunosuppressants drugs | 0 | - | - | - | - | |
leflunomide | 0 | - | - | - | - | |
pirfenidone | 0 | - | - | - | - | |
Polyinosinic-Polycytidylic Acid | 0 | - | - | - | - | |
sargramostim | 0 | - | - | - | - | |
thymosin | 0 | - | - | - | - |